Role of Intravenous Levetiracetam in Seizure Prophylaxis of Severe Traumatic Brain Injury Patients
Open Access
- 1 January 2013
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 4, 170
Abstract
Traumatic brain injury (TBI) can cause seizures and the development of epilepsy. The incidence of seizures varies from 21% in patients with severe brain injuries to 50% in patients with war-related penetrating TBI. In the acute and sub-acute periods following injury, seizures can lead to increased intracranial pressure and cerebral edema, further complicating TBI management. Anticonvulsants can be used for seizure prophylaxis according to the current Parameters of Practice and Guidelines in a subset of severe TBI patients, and for a limited time window. Phenytoin is the most widely prescribed anticonvulsant in these patients. Intravenous levetiracetam, made available in 2006, is now being considered as a viable option in acute care settings if phenytoin is unavailable or not feasible due to side-effects. We discuss current data regarding the role of intravenous levetiracetam in seizure prophylaxis of severe TBI patients and the need for future studies.Keywords
This publication has 25 references indexed in Scilit:
- Changing trends in the use of seizure prophylaxis after traumatic brain injury: A shift from phenytoin to levetiracetamJournal of Critical Care, 2013
- A prospective multicenter comparison of levetiracetam versus phenytoin for early posttraumatic seizure prophylaxisJournal of Trauma and Acute Care Surgery, 2013
- Phenytoin versus Leviteracetam for Seizure Prophylaxis after brain injury – a meta analysisBMC Neurology, 2012
- Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injuryNeurosurgical Focus, 2008
- Cutaneous Drug Eruptions by Current AntiepilepticsClinical Neuropharmacology, 2008
- III. Prophylactic HypothermiaJournal of Neurotrauma, 2007
- Hypothalamic-pituitary-adrenal axis dysfunction in critically ill patients with traumatic brain injury: Incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels*Critical Care Medicine, 2004
- Valproate therapy for prevention of posttraumatic seizures: a randomized trialJournal of Neurosurgery, 1999
- Phenytoin Causes a Rapid Increase in 6β‐Hydroxycortisol Urinary Excretion in Humans—A Putative Measure of CYP3A InductionJournal of Pharmaceutical Sciences, 1995
- Phenytoin: Basic and clinical pharmacologyMedicinal Research Reviews, 1983